CNETS is committed to improving NET patients’ quality of life and survival across Canada. To deliver on this vision, CNETS  has supported NET research since 2011, initially through a partnership-based approach and since 2016 through our independent Research Funding Framework.

This marks the ninth year of our significant contribution to NET cancer research in Canada. We are proud to have offered research grants across the country based on our framework. The dedication and commitment of the NET community have made this possible!

Relevance of the application to the focused area of Neuroendocrine Tumour (NET) cancer research.

The eligible project must involve a clinical trial or a clinical or fundamental research project (including animal or cellular models) to examine issues relevant for the understanding of the origin and development of Neuroendocrine tumors (NETs), their diagnosis and treatment.

The onus is on the applicant to justify the request in terms of its relevance to the diagnosis and therapy for NET patients by these selected approaches.

Preference will be given to projects that could have a direct and meaningful impact on the lives NET patients.

To harness the unique insight only a patient or caregiver can provide, CNETS encourages applications with patient and caregiver engagement in the project design and execution.